August 2, 2011 – The U.S. Food and Drug Administration said it recently cleared Abbott Vascular’s RX Herculink Elite ...
Navigating through the world of coronary stents is about to become more complex. A plethora of new products are on the ...
In a move that will likely have a significant impact on how many patients are treated for carotid artery disease, the U ...
June 3, 2011 - Research presented at the International Federation of Clinical Chemistry Congress and Laboratory Medicine ...
May 25, 2011 – The U.S. Food and Drug Administration (FDA) cleared the Xience nano everolimus-eluting coronary stent ...
The transcatheter MitraClip mitral valve repair system continues to compare favorably with conventional open-heart ...
April 6, 2011 – Data from the EVEREST II study show that patients with significant mitral regurgitation (MR) continue to ...
April 6, 2011 – The second phase of a trial evaluating the world’s first drug-eluting bioresorbable vascular scaffold ...
April 6, 2011 – A pooled analysis of the SPIRIT II, III, IV and COMPARE trials further reinforces the positive clinical ...